@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:336296_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Anticuerpos neutralizadores que reducen o eliminan la actividad biológica de un antígeno soluble o un agente infeccioso (p. ej., el VIH) mediante la focalización de varios epítopos."@es, "Neutralizing antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent (e.g., HIV) by targeting several epitopes."@en ;
  dc:source "Medical Subject Headings" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Topic>
  a owl:Class ;
  rdfs:label "Topic"@en .

nalt:336296
  a <https://lod.nal.usda.gov/naltv#Topic>, skos:Concept ;
  dc:created "2020-02-18"^^xsd:date ;
  dc:modified "2020-10-29"^^xsd:date ;
  skos:altLabel "broad spectrum antibodies"@en, "cross-neutralizing antibodies"@en ;
  skos:broader nalt:206471 ;
  skos:definition nalt:336296_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "anticuerpos ampliamente neutralizadores"@es, "broadly neutralizing antibodies"@en ;
  skos:related nalt:10349 ;
  ns0:marc001 "95122" .

nalt:10349
  a ns0:Topic, skos:Concept ;
  skos:prefLabel "epitopos"@es, "epitopes"@en ;
  skos:related nalt:336296 .

nalt:206471
  a ns0:Topic, skos:Concept ;
  skos:narrower nalt:336296 ;
  skos:prefLabel "anticuerpos neutralizantes"@es, "neutralizing antibodies"@en .

